Correlation between Foxp3 protein and peritoneal metastasis in gastric cancer

CHEN Lei,LI Maolan,WENG Hao,YANG Jiahua,ZHANG Wenjie,LU Jianhua,DONG Ping,GU Jun,LIU Yingbin

2012-01-01

Abstract:Objective To investigate the relationship between the expression of Foxp3 protein and peritoneal metastasis in gastric cancer.Methods The expressions of Foxp3 was detected in matching samples including primary gastric cancer lesions, lymph node metastases, peritoneal metastases and normal tissues by immunohistochemistry. The specimens were obtained from 65 patients who had synchronous peritoneal metastasis from gastric cancer. Results The expression of Foxp3 was 78.5% (51/65), 80.0% (52/65), 88.6% (39/44) and 20.0% (13/65) in the gastric cancer lesions, peritoneal metastases, lymph node metastases and normal tissures, respectively. As compared with normal tissues, the expression of Foxp3 in the gastric carcinoma lesions, peritoneal metastases and lymph node metastases was significantly increased (all P<0.05); but there were no significant differences among the gastric cancer lesions, peritoneal metastases and lymph node metastases (all P>0.05).The expression of Foxp3 was not correlated with age and sex of the patients (both P>0.05), whereas it was negatively correlated with histological differentiation (r=-0.301, P=0.023) and positively correlated with lymph node metastases (r=0.358, P=0.004). Conclusion The expression of Foxp3 in gastric cancer lesions can be used as a biological marker of peritoneal metastasis from gastric cancer before operation and patient prognosis.